MoneyWorks4Me

Zenotech Laboratories informs about disclosure

30 Mar 2022 Evaluate
Pursuant to Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011 (SEBI SAST Regulations, 2011), Zenotech Laboratories has informed that the Company has received intimation regarding inter-se transfer of shares between two promoters.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..